How is age-related macular degeneration currently treated?

Regular monitoring by an eye-care professional, including home monitoring of central vision when advised. For intermediate AMD, specific nutritional supplement formulations studied by the National Eye Institute (AREDS/AREDS2) may be recommended by a clinician. For wet AMD, intravitreal anti-VEGF injections are established care. Low-vision rehabilitation and assistive devices. EyeCyte is educational; treatment decisions belong with a licensed eye-care professional.

⚠ Important — educational information only, not medical advice

EyeCyte provides educational and scientific information and does not provide medical advice, diagnosis, or treatment. Emerging regenerative and biologic technologies discussed on this website may be experimental, investigational, unapproved, or supported only by preclinical evidence. Patients should discuss medical decisions with appropriately licensed healthcare professionals.
Not an FDA-approved treatment unless explicitly stated. Except where a page names an FDA-approved product, the stem-cell, MSC, exosome, extracellular-vesicle, Wharton’s jelly and other biologic approaches described here are not FDA-approved for any eye condition. Research findings — especially laboratory and animal studies — are not proof that anything works or is safe in people.
Research-Use-Only (RUO): Research-Use-Only (RUO) materials referenced on EyeCyte are for laboratory research by qualified professionals only. They are not drugs, biologics or devices approved for human use, are not intended for administration to people, and are not intended to diagnose, treat, cure, mitigate or prevent any disease.
EyeCyte does not sell, offer, recommend or refer for treatment. Be cautious of any clinic offering unapproved stem-cell or biologic injections for the eye; the FDA has warned of serious harm, including blindness.

Full medical disclaimer · RUO policy · Medical review policy

Read the full page: Age-Related Macular Degeneration →Find an Eye-Care Professional

How is age-related macular degeneration currently treated?

Related questions